WuXi PharmaTech appoints new CFO
WuXi PharmaTech, a pharmaceutical and biotechnology company, has appointed Edward Hu as its new CFO.
WuXi PharmaTech a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced revently that it has signed a new three-year, in vitro ADME collaboration agreement with Pfizer.